FRI0030 Higher levels of serum interleukin-20 are associated with better response to disease-modifying antirheumatic drugs in patients with resent-onset rheumatoid arthritis

Abstract

BackgroundInterleukin-20 (IL-20), a recently identified potent pro-inflammatory, angiogenic and chemoattractive cytokine, plays a significant role in the pathogenesis of rheumatoid arthritis (RA). Activated monocytes and dendritic cells are the main...